Risk factors for depression and anxiety in painful and painless diabetic polyneuropathy: A multicentre observational cross-sectional study.
Journal
European journal of pain (London, England)
ISSN: 1532-2149
Titre abrégé: Eur J Pain
Pays: England
ID NLM: 9801774
Informations de publication
Date de publication:
02 2022
02 2022
Historique:
received:
03
05
2021
accepted:
22
09
2021
pubmed:
1
10
2021
medline:
5
3
2022
entrez:
30
9
2021
Statut:
ppublish
Résumé
Despite the high prevalence of depression and anxiety in chronic pain conditions, current knowledge concerning emotional distress among painful diabetic polyneuropathy (pDSPN) and other diabetes mellitus (DM) sufferers is limited. This observational multicentre cohort study employed the Hospital Anxiety and Depression Scale, the Beck Depression Inventory II and the State-Trait Anxiety Inventory to assess symptoms of depression and anxiety in several groups with diabetes, as well as in a control group. The study cohort included 347 pDSPN patients aged 63.4 years (median), 55.9% males; 311 pain-free diabetic polyneuropathy (nDSPN) patients aged 63.7 years, 57.9% males; 50 diabetes mellitus (DM) patients without polyneuropathy aged 61.5 years, 44.0% males; and 71 healthy controls (HC) aged 63.0 years, 42.3% males. The roles played in emotional distress were explored in terms of the biological, the clinical (diabetes-, neuropathy- and pain-related), the socio-economic and the cognitive factors (catastrophizing). The study disclosed a significantly higher prevalence of the symptoms of depression and anxiety not only in pDSPN (46.7% and 60.7%, respectively), but also in patients with nDSPN (24.4% and 44.4%) and DM without polyneuropathy (22.0% and 30.0%) compared with HCs (7.0% and 14.1%, p < 0.001). Multiple regression analysis demonstrated the severity of pain and neuropathy, catastrophic thinking, type 2 DM, lower age and female sex as independent contributors to depression and anxiety. In addition to the severity of neuropathic pain and its cognitive processing, the severity of diabetic polyneuropathy and demographic factors are key independent contributors to emotional distress in diabetic individuals. In large cohorts of well-defined painless and painful diabetic polyneuropathy patients and diabetic subjects without polyneuropathy, we found a high prevalence of the symptoms of depression and anxiety, mainly in painful individuals. We have confirmed neuropathic pain, its severity and cognitive processing (pain catastrophizing) as dominant risk factors for depression and anxiety. Furthermore, some demographic factors (lower age, female sex), type 2 diabetes mellitus and severity of diabetic polyneuropathy were newly identified as important contributors to emotional distress independent of pain.
Sections du résumé
BACKGROUND
Despite the high prevalence of depression and anxiety in chronic pain conditions, current knowledge concerning emotional distress among painful diabetic polyneuropathy (pDSPN) and other diabetes mellitus (DM) sufferers is limited.
METHODS
This observational multicentre cohort study employed the Hospital Anxiety and Depression Scale, the Beck Depression Inventory II and the State-Trait Anxiety Inventory to assess symptoms of depression and anxiety in several groups with diabetes, as well as in a control group. The study cohort included 347 pDSPN patients aged 63.4 years (median), 55.9% males; 311 pain-free diabetic polyneuropathy (nDSPN) patients aged 63.7 years, 57.9% males; 50 diabetes mellitus (DM) patients without polyneuropathy aged 61.5 years, 44.0% males; and 71 healthy controls (HC) aged 63.0 years, 42.3% males. The roles played in emotional distress were explored in terms of the biological, the clinical (diabetes-, neuropathy- and pain-related), the socio-economic and the cognitive factors (catastrophizing).
RESULTS
The study disclosed a significantly higher prevalence of the symptoms of depression and anxiety not only in pDSPN (46.7% and 60.7%, respectively), but also in patients with nDSPN (24.4% and 44.4%) and DM without polyneuropathy (22.0% and 30.0%) compared with HCs (7.0% and 14.1%, p < 0.001). Multiple regression analysis demonstrated the severity of pain and neuropathy, catastrophic thinking, type 2 DM, lower age and female sex as independent contributors to depression and anxiety.
CONCLUSIONS
In addition to the severity of neuropathic pain and its cognitive processing, the severity of diabetic polyneuropathy and demographic factors are key independent contributors to emotional distress in diabetic individuals.
SIGNIFICANCE
In large cohorts of well-defined painless and painful diabetic polyneuropathy patients and diabetic subjects without polyneuropathy, we found a high prevalence of the symptoms of depression and anxiety, mainly in painful individuals. We have confirmed neuropathic pain, its severity and cognitive processing (pain catastrophizing) as dominant risk factors for depression and anxiety. Furthermore, some demographic factors (lower age, female sex), type 2 diabetes mellitus and severity of diabetic polyneuropathy were newly identified as important contributors to emotional distress independent of pain.
Identifiants
pubmed: 34592017
doi: 10.1002/ejp.1865
pmc: PMC9293147
doi:
Types de publication
Journal Article
Multicenter Study
Observational Study
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
370-389Informations de copyright
© 2021 The Authors. European Journal of Pain published by John Wiley & Sons Ltd on behalf of European Pain Federation - EFIC ®.
Références
J Diabetes Complications. 2017 Aug;31(8):1318-1324
pubmed: 28599823
Diabetes Care. 2006 Jul;29(7):1518-22
pubmed: 16801572
Curr Diab Rep. 2013 Aug;13(4):533-49
pubmed: 23677582
Pain. 2010 Dec;151(3):598-605
pubmed: 20965658
Diabetes Care. 2013 Jan;36 Suppl 1:S67-74
pubmed: 23264425
J Psychiatr Res. 2007 Apr-Jun;41(3-4):207-13
pubmed: 17113600
Pain. 1995 Sep;62(3):363-372
pubmed: 8657437
Pain. 2004 Apr;108(3):248-257
pubmed: 15030944
J Neurol Neurosurg Psychiatry. 2002 May;72(5):596-601
pubmed: 11971045
Addiction. 1993 Jun;88(6):791-804
pubmed: 8329970
Pain. 2004 Jan;107(1-2):159-66
pubmed: 14715402
Pain. 1992 Aug;50(2):133-149
pubmed: 1408309
Mayo Clin Proc. 2010 Mar;85(3 Suppl):S42-50
pubmed: 20194148
J Psychiatr Res. 2010 May;44(7):454-61
pubmed: 20149391
Diabetes Care. 2000 Jul;23(7):934-42
pubmed: 10895843
Braz J Psychiatry. 2013 Oct-Dec;35(4):416-31
pubmed: 24402217
Diabetes Res Clin Pract. 2000 Feb;47(2):123-8
pubmed: 10670912
Phys Ther. 2011 May;91(5):754-64
pubmed: 21451092
Diab Vasc Dis Res. 2014 May 12;11(4):218-225
pubmed: 24821753
J Adv Nurs. 2005 Jul;51(2):158-65
pubmed: 15963187
Child Psychiatry Hum Dev. 2007 Oct;38(3):171-81
pubmed: 17406972
Pain. 2016 Aug;157(8):1599-1606
pubmed: 27115670
Pain. 2017 Dec;158(12):2340-2353
pubmed: 28858986
Eur J Pain. 2022 Feb;26(2):370-389
pubmed: 34592017
Psychosom Med. 2001 Jul-Aug;63(4):619-30
pubmed: 11485116
Curr Pain Headache Rep. 2013 May;17(5):330
pubmed: 23512722
Pain. 2006 Aug;123(3):231-243
pubmed: 16697110
Dialogues Clin Neurosci. 2017 Jun;19(2):127-136
pubmed: 28867937
Pain Med. 2010 Feb;11(2):158-79
pubmed: 19788712
Neurology. 2008 Apr 29;70(18):1630-5
pubmed: 18003941
Pain. 2016 May;157(5):1132-1145
pubmed: 27088890
Eur J Pain. 2020 Sep;24(8):1624-1634
pubmed: 32538517
J Affect Disord. 2017 Jan 15;208:191-197
pubmed: 27792962
Diabetes Care. 2010 Oct;33(10):2285-93
pubmed: 20876709
JAMA. 1998 Jul 8;280(2):147-51
pubmed: 9669787
Diabet Med. 2009 Mar;26(3):240-6
pubmed: 19317818
Diabet Med. 2009 Feb;26(2):153-61
pubmed: 19236618
J Psychosom Res. 1997 Jan;42(1):17-41
pubmed: 9055211
Arthritis Rheum. 2007 Apr 15;57(3):415-22
pubmed: 17394226